Financhill
Buy
71

BCS Quote, Financials, Valuation and Earnings

Last price:
$17.70
Seasonality move :
-1.55%
Day range:
$17.76 - $18.05
52-week range:
$10.17 - $18.05
Dividend yield:
2.43%
P/E ratio:
9.11x
P/S ratio:
1.91x
P/B ratio:
0.66x
Volume:
12.7M
Avg. volume:
14.1M
1-year change:
57.67%
Market cap:
$63.9B
Revenue:
$33.5B
EPS (TTM):
$1.97

BCS Analysts' Consensus Rating

The 2 analysts providing 12-month price projections for Barclays PLC shares anticipate an average target of $18.05, ranging from a low estimate of $16.30 to a high estimate of $19.80. This average target implies a growth of 0.33% compared to the current stock price of $17.99.

Consensus Price Target

$18.05

Highest Price Target

$19.80

Lowest Price Target

$16.30

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 0 1 1

Hold 1 1 1

Sell 0 0 0
Consensus Hold Leans Bullish Leans Bullish

BCS Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is It Time to Sell MercadoLibre?
Is It Time to Sell MercadoLibre?

MercadoLibre (NASDAQ:MELI) has earned a reputation for being not dissimilar…

Is Tesla Stock High Risk or High Reward?
Is Tesla Stock High Risk or High Reward?

EV-making supergiant Tesla, Inc. (NASDAQ:TSLA) is going through a difficult…

Why Did Chase Coleman Buy TSM?
Why Did Chase Coleman Buy TSM?

Billionaire Chase Coleman of Tiger Global Management has built a…

Stock Ideas

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 48x

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Sell
43
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Buy
55
CTRN alert for Jun 4

Citi Trends [CTRN] is up 2.77% over the past day.

Sell
44
RGC alert for Jun 4

Regencell Bioscience Holdings [RGC] is up 3.45% over the past day.

Buy
63
MLTX alert for Jun 4

MoonLake Immunotherapeutics [MLTX] is up 5.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock